Arca Biopharma reported $0 in Interest Expense on Debt for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Amgen AMGN:US $ 328M 33M
Arca Biopharma ABIO:US $ 0 0
Biogen BIIB:US $ 65.8M 0.3M
Bristol Myers Squibb BMY:US $ 313M 13M
Cytokinetics CYTK:US $ 2.81M 0.06M
Gilead Sciences GILD:US $ 242M 4M
Laboratory Of America LH:US $ 42.5M 0.3M
Pfizer PFE:US $ 293M 29M
United Therapeutics UTHR:US $ 6.2M 1.5M